Michael Thomas Henderson, Chief Executive Officer at Apogee Therapeutics, Inc. (APGE), sold 20,000 shares at $74.29 ($1.5M) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Open-market sale of $1.5M APGE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.29 | 8,363 | $621K | 41.5% |
| 2 | $74.83 | 8,219 | $615K | 41.1% |
| 3 | $75.86 | 3,418 | $259K | 17.3% |
| Total | $74.78 avg | 20,000 | $1.5M | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |